Therapeutic options in patients with reduced ejection fraction and nonsustained ventricular tachycardia

Research output: Contribution to journalArticle

Abstract

The patient with a reduced ejection fraction and nonsustained ventricular tachycardia represents a common management problem for the physician. This article reviews the supporting evidence for the therapeutic options available for these patients according to the etiology of the reduced ejection fraction. In postinfarction patients, electrophysiology-guided implantable cardioverter defibrillator therapy improves survival more than antiarrhythmic therapy. In patients with nonischemic cardiomyopathy, the best therapy is yet undetermined. Ongoing clinical trials will hopefully direct future therapy.

Original languageEnglish (US)
Pages (from-to)219-223
Number of pages5
JournalCurrent cardiology reports
Volume3
Issue number3
DOIs
StatePublished - Dec 1 2001

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Therapeutic options in patients with reduced ejection fraction and nonsustained ventricular tachycardia'. Together they form a unique fingerprint.

  • Cite this